Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-Masked, Randomized, Vehicle-Controlled 12-Month Parallel Comparison of the Safety and Efficacy of 0.1% and 0.2% CBT-001 Versus Vehicle, Dosed Twice-Daily, in Patients With Pterygium

NCT05456425 is registered in ClinicalTrials.gov with Cloudbreak Therapeutics, LLC as lead sponsor.

NCT NCT05456425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05456425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-Masked, Randomized, Vehicle-Controlled 12-Month Parallel Comparison of the Safety and Efficacy of 0.1% and 0.2% CBT-001 Versus Vehicle, Dosed Twice-Daily, in Patients With Pterygium
Lead sponsor
Cloudbreak Therapeutics, LLC
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 30, 2022
Completion date
December 31, 2027
Enrollment
660 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

pterygium